IS7193A - Lyfjablanda með kítósan óligómerum - Google Patents

Lyfjablanda með kítósan óligómerum

Info

Publication number: IS7193A
Authority: IS; Iceland
Prior art keywords: oligomers; medicinal composition; treatment; compositions; chitosan oligomers
Prior art date: 2001-09-26

Application number

IS7193A

Other languages

English (en)

Other versions

IS2783B (is

Inventor

Gíslason Johannes

M. Einarsson Jon

Peter Martin

Original Assignee

Genis Ehf.

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-09-26

Filing date

2004-03-22

Publication date

2004-03-22

2004-03-22 Application filed by Genis Ehf. filed Critical Genis Ehf.

2004-03-22 Publication of IS7193A publication Critical patent/IS7193A/is

2012-05-15 Publication of IS2783B publication Critical patent/IS2783B/is

Links

239000000203 mixture Substances 0.000 title abstract 3
229920001661 Chitosan Polymers 0.000 title 1
208000012659 Joint disease Diseases 0.000 abstract 2
OVRNDRQMDRJTHS-UHFFFAOYSA-N N-acelyl-D-glucosamine Natural products CC(=O)NC1C(O)OC(CO)C(O)C1O OVRNDRQMDRJTHS-UHFFFAOYSA-N 0.000 abstract 2
OVRNDRQMDRJTHS-FMDGEEDCSA-N N-acetyl-beta-D-glucosamine Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O OVRNDRQMDRJTHS-FMDGEEDCSA-N 0.000 abstract 2
MBLBDJOUHNCFQT-LXGUWJNJSA-N N-acetylglucosamine Natural products CC(=O)N[C@@H](C=O)[C@@H](O)[C@H](O)[C@H](O)CO MBLBDJOUHNCFQT-LXGUWJNJSA-N 0.000 abstract 2
229950006780 n-acetylglucosamine Drugs 0.000 abstract 2
MSWZFWKMSRAUBD-IVMDWMLBSA-N 2-amino-2-deoxy-D-glucopyranose Chemical compound N[C@H]1C(O)O[C@H](CO)[C@@H](O)[C@@H]1O MSWZFWKMSRAUBD-IVMDWMLBSA-N 0.000 abstract 1
229920002101 Chitin Polymers 0.000 abstract 1
MSWZFWKMSRAUBD-UHFFFAOYSA-N beta-D-galactosamine Natural products NC1C(O)OC(CO)C(O)C1O MSWZFWKMSRAUBD-UHFFFAOYSA-N 0.000 abstract 1
230000006196 deacetylation Effects 0.000 abstract 1
238000003381 deacetylation reaction Methods 0.000 abstract 1
229960002442 glucosamine Drugs 0.000 abstract 1
230000002757 inflammatory effect Effects 0.000 abstract 1
238000000034 method Methods 0.000 abstract 1
201000008482 osteoarthritis Diseases 0.000 abstract 1
239000008194 pharmaceutical composition Substances 0.000 abstract 1
206010039073 rheumatoid arthritis Diseases 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/716—Glucans
- A61K31/722—Chitin, chitosan
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H13/00—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
- C07H13/02—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids
- C07H13/04—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids having the esterifying carboxyl radicals attached to acyclic carbon atoms
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
- C08B37/0024—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid beta-D-Glucans; (beta-1,3)-D-Glucans, e.g. paramylon, coriolan, sclerotan, pachyman, callose, scleroglucan, schizophyllan, laminaran, lentinan or curdlan; (beta-1,6)-D-Glucans, e.g. pustulan; (beta-1,4)-D-Glucans; (beta-1,3)(beta-1,4)-D-Glucans, e.g. lichenan; Derivatives thereof
- C08B37/0027—2-Acetamido-2-deoxy-beta-glucans; Derivatives thereof
- C08B37/003—Chitin, i.e. 2-acetamido-2-deoxy-(beta-1,4)-D-glucan or N-acetyl-beta-1,4-D-glucosamine; Chitosan, i.e. deacetylated product of chitin or (beta-1,4)-D-glucosamine; Derivatives thereof

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Medicinal Chemistry (AREA)
Molecular Biology (AREA)
Chemical Kinetics & Catalysis (AREA)
Biochemistry (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Genetics & Genomics (AREA)
Polymers & Plastics (AREA)
Bioinformatics & Cheminformatics (AREA)
Physical Education & Sports Medicine (AREA)
Rheumatology (AREA)
Biotechnology (AREA)
Materials Engineering (AREA)
Orthopedic Medicine & Surgery (AREA)
Pain & Pain Management (AREA)
Immunology (AREA)
Epidemiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Polysaccharides And Polysaccharide Derivatives (AREA)

IS7193A 2001-09-26 2004-03-22 Lyfjasamsetning sem nær yfir kító-fáliður IS2783B (is)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
IS6085A IS6085A (is)	2001-09-26	2001-09-26	Lyfjablanda með kítósan óligómerum
PCT/IS2002/000016 WO2003026677A1 (en)	2001-09-26	2002-09-26	Pharmaceutical composition comprising chito-oligomers

Publications (2)

Publication Number	Publication Date
IS7193A true IS7193A (is)	2004-03-22
IS2783B IS2783B (is)	2012-05-15

Family

ID=36700489

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
IS6085A IS6085A (is)	2001-09-26	2001-09-26	Lyfjablanda með kítósan óligómerum
IS7193A IS2783B (is)	2001-09-26	2004-03-22	Lyfjasamsetning sem nær yfir kító-fáliður

Family Applications Before (1)

Application Number	Title	Priority Date	Filing Date
IS6085A IS6085A (is)	2001-09-26	2001-09-26	Lyfjablanda með kítósan óligómerum

Country Status (13)

Country	Link
US (2)	US7985741B2 (is)
EP (1)	EP1435976B1 (is)
JP (1)	JP4613008B2 (is)
KR (1)	KR20040062548A (is)
AT (1)	ATE359797T1 (is)
CA (1)	CA2507926C (is)
DE (1)	DE60219653T2 (is)
DK (1)	DK1435976T3 (is)
ES (1)	ES2284935T3 (is)
IS (2)	IS6085A (is)
PT (1)	PT1435976E (is)
SI (1)	SI1435976T1 (is)
WO (1)	WO2003026677A1 (is)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AU2002351576A1 (en) *	2001-12-13	2003-07-09	Ism Biopolymer Inc.	Method of modulating release of saccharides and uses thereof
GB0321996D0 (en) *	2003-09-19	2003-10-22	Novartis Nutrition Ag	Organic compounds
CA2540586A1 (en) *	2003-10-01	2005-04-21	Optimer Pharmaceuticals, Inc.	Treatment of a condition in a mammal with administration of aminosugar and uses thereof
US20070082851A1 (en) *	2003-11-24	2007-04-12	Optimer Pharmaceuticals Inc.	Treatment of a condition in a mammal with administration of Compounds and Methods of Use
EP1749532B1 (en) *	2004-05-21	2014-04-23	Tottori University	Drug for remedy or treatment of wound
CA2611453C (en) *	2005-06-14	2015-10-06	Genis Ehf.	Compositions of partially deacetylated chitin derivatives
WO2007001283A2 (en) *	2005-06-16	2007-01-04	E.I. Dupont De Nemours And Company	Chemical synthesis of low molecular weight polyglucosamines and polygalactosamines
US7485718B2 (en)	2005-06-16	2009-02-03	E. I. Du Pont De Nemours And Company	Chemical synthesis of low molecular weight polyglucosamines and polygalactosamines
KR100831335B1 (ko) *	2006-06-22	2008-05-22	부경대학교 산학협력단	인간 피부 섬유아세포에서 메트릭스메탈로프로테이나제-2의 발현 및 활성을 억제시키는키토올리고사카라이드 화합물 및 이를 함유한 메트릭스메탈로프로테이나제-2 억제제
CN102159218B (zh) *	2008-07-18	2015-12-02	杰尼斯Ehf公司	用于医学用途的新型几丁低聚物组合物
KR20100060634A (ko) *	2008-11-28	2010-06-07	(주)아모레퍼시픽	미토콘드리아 활성화를 위한 조성물
KR101729137B1 (ko) *	2009-07-28	2017-04-26	(주)아모레퍼시픽	키토올리고당을 함유하는 피로회복용 조성물
WO2012167226A2 (en)	2011-06-03	2012-12-06	Maguire Abbey, Llc	Method, composition, and articles for improving joint lubrication
IN2014CN02468A (is)	2011-09-08	2015-06-19	Novozymes Bioag As
CA2848856C (en)	2011-09-14	2020-04-28	Novozymes Bioag A/S	Use of lipochito-oligosaccharides and/or chito-oligosaccharides in combination with phosphate-solubilizing microorganisms to enhance plant growth
MX2014003411A (es) *	2011-09-23	2015-03-19	Novozymes Bioag As	Quitooligosacaridos y metodos para el uso en el mejoramiento del crecimiento del maiz.
MX351416B (es) *	2011-09-23	2017-10-13	Novozymes Bioag As	Quitooligosacaridos y metodos para el uso en el mejoramiento de crecimiento de plantas.
DK2841114T3 (en)	2012-04-23	2018-09-24	Genis Hf	SELF-HARDING BIOACTIVE CEMENT COMPOSITIONS WITH PARTIAL DEACETYLATED CHITIN AS BONE TRANSPLANT REPLACEMENTS
JP6285497B2 (ja) *	2016-06-07	2018-02-28	株式会社エバーライフ	鶏冠抽出物含有経口組成物及び鶏冠抽出物の香味に由来する摂取困難性の改善方法
KR101673368B1 (ko)	2016-07-14	2016-11-08	김기혁	공정가스 반응물의 콜드트랩 장치
CN119156219A (zh) *	2022-04-21	2024-12-17	塞拉珀蒂科什股份有限公司	治疗发炎的方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPS5919122B2 (ja) *	1976-10-12	1984-05-02	味の素株式会社	水溶性部分脱アセチル化キチン及びその製造法
US4532134A (en) *	1981-04-06	1985-07-30	Malette William Graham	Method of achieving hemostasis, inhibiting fibroplasia, and promoting tissue regeneration in a tissue wound
JP2527317B2 (ja)	1986-12-19	1996-08-21	ライオン株式会社	骨疾患治療剤
US6184037B1 (en) *	1996-05-17	2001-02-06	Genemedicine, Inc.	Chitosan related compositions and methods for delivery of nucleic acids and oligonucleotides into a cell
CA2274510C (en)	1996-12-13	2010-02-16	Lescarden, Inc.	Treatment of osteoarthritis by administering poly-n-acetyl-d-glucosamine
JP3062592B2 (ja) *	1997-05-30	2000-07-10	農林水産省食品総合研究所長	２−アセチルアミノ−４−Ｏ−（２−アミノ−２−デオキシ−β−Ｄ −グルコピラノシル）−２−デオキシ−Ｄ −グルコースおよびその塩の製造法
US6492350B2 (en) *	2000-01-27	2002-12-10	Jdc (Hawaii) Inc.	Chitin oligosaccharides and/or chitosan oligosaccharides for preventing or treating common cold or treating pain
EP1127574A1 (en)	2000-02-22	2001-08-29	Food Industry Research and Development Institute	Use of chitinous materials for inhibiting cellular nitric oxide production
CA2313836C (en)	2000-03-15	2009-06-09	Cargill, Incorporated	Chitosan and method of preparing chitosan
US20020119949A1 (en)	2001-02-26	2002-08-29	Asa Hellman	Prophylactic teat treatment
CA2611453C (en) *	2005-06-14	2015-10-06	Genis Ehf.	Compositions of partially deacetylated chitin derivatives

2001
- 2001-09-26 IS IS6085A patent/IS6085A/is unknown
2002
- 2002-09-26 WO PCT/IS2002/000016 patent/WO2003026677A1/en not_active Ceased
- 2002-09-26 KR KR10-2004-7004323A patent/KR20040062548A/ko not_active Ceased
- 2002-09-26 CA CA2507926A patent/CA2507926C/en not_active Expired - Lifetime
- 2002-09-26 ES ES02777769T patent/ES2284935T3/es not_active Expired - Lifetime
- 2002-09-26 US US10/490,637 patent/US7985741B2/en active Active
- 2002-09-26 DK DK02777769T patent/DK1435976T3/da active
- 2002-09-26 AT AT02777769T patent/ATE359797T1/de active
- 2002-09-26 DE DE60219653T patent/DE60219653T2/de not_active Expired - Lifetime
- 2002-09-26 JP JP2003530312A patent/JP4613008B2/ja not_active Expired - Lifetime
- 2002-09-26 EP EP02777769A patent/EP1435976B1/en not_active Expired - Lifetime
- 2002-09-26 SI SI200230558T patent/SI1435976T1/sl unknown
- 2002-09-26 PT PT02777769T patent/PT1435976E/pt unknown
2004
- 2004-03-22 IS IS7193A patent/IS2783B/is unknown
2011
- 2011-06-20 US US13/164,397 patent/US8415326B2/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
EP1435976B1 (en)	2007-04-18
DE60219653D1 (de)	2007-05-31
DE60219653T2 (de)	2008-01-03
US8415326B2 (en)	2013-04-09
ES2284935T3 (es)	2007-11-16
PT1435976E (pt)	2007-06-28
US7985741B2 (en)	2011-07-26
SI1435976T1 (sl)	2007-08-31
IS6085A (is)	2003-03-27
JP4613008B2 (ja)	2011-01-12
DK1435976T3 (da)	2007-08-27
WO2003026677A1 (en)	2003-04-03
EP1435976A1 (en)	2004-07-14
IS2783B (is)	2012-05-15
US20050004073A1 (en)	2005-01-06
ATE359797T1 (de)	2007-05-15
US20110257381A1 (en)	2011-10-20
CA2507926C (en)	2011-12-20
CA2507926A1 (en)	2003-04-03
JP2005507891A (ja)	2005-03-24
KR20040062548A (ko)	2004-07-07

Publication	Publication Date	Title
IS7193A (is)	2004-03-22	Lyfjablanda með kítósan óligómerum
CA2303498A1 (en)	2000-09-30	Dioxocyclopentyl hydroxamic acids
EP2085780A3 (en)	2011-08-17	Methods and products related to low molecular weight heparin
EA202193053A1 (ru)	2022-03-21	Хитозан и его применения
BR0010209A (pt)	2002-02-19	Composições para o tratamento de desordens do esÈfago
AU2003901834A0 (en)	2003-05-01	Cross-linked polysaccharide compositions
WO2008015249A3 (en)	2008-05-08	Cosmetic or pharmaceutical composition containing hyaluronic acid
NZ624749A (en)	2015-07-31	A sulfated polysaccharide compound and the preparation and use thereof
ATE479453T1 (de)	2010-09-15	Polymermischungen von anionischen und kationischen polysacchariden und verwendung davon
EP2497478A3 (en)	2012-11-07	Oligosaccaride compositions and use thereof in the treatment of infection
WO2002018448A3 (en)	2002-05-16	Percarboxylated polysaccharides, and a process for their preparation
MX375577B (es)	2025-03-06	Composiciones de derivados de quitina parcialmente desacetilados.
JP2005507891A5 (is)	2006-01-12
ES2161615A1 (es)	2001-12-01	Composiciones de heparinas de muy bajo peso molecular.
ATE441333T1 (de)	2009-09-15	Zusammensetzung enthaltend oligosaccharide als lísliche ballaststoffe zur verwendung gegen muskelschwund
GB0310919D0 (en)	2003-06-18	Pharmaceutical compositions
SV2003001201A (es)	2003-03-18	Preparados de chitosan
BR0316493A (pt)	2005-10-11	ésteres de ácido aldÈnico, métodos para produzir os mesmos, e métodos para produzir ingredientes ativos farmacêuticos ligados a polissacarìdicos ou derivados polissacarìdeos sobre grupos amino livres
NO20010940D0 (no)	2001-02-23	TAN-1057 derivater
IS6914A (is)	2003-08-15	2-þíó-útskiptar imídasólafleiður og notkun þeirraí lyfjaiðnaðinum
TW200510012A (en)	2005-03-16	Aqua gel comprising temperature effect
DK1366082T3 (da)	2006-03-06	Höjsulfaterede derivater af K5-polysaccharid og deres fremstilling
ITMI20021801A1 (it)	2004-02-09	Prodotti di pomodoro.
ATE328603T1 (de)	2006-06-15	Modulatoren von polysacchariden und deren verwendungen
BR9609416A (pt)	1999-12-14	Agentes antivìrus.